Clinical Trials Directory

Trials / Unknown

UnknownNCT05347381

Selinexol Combined With Dexamethasone in the Treatment of CAEBV

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
6 (estimated)
Sponsor
Beijing Friendship Hospital · Academic / Other
Sex
All
Age
14 Years – 70 Years
Healthy volunteers
Not accepted

Summary

This study is a single-center, prospective, observational clinical study to evaluate the Effecive and Safty of Selinexol and Dexamethasone in CAEBV

Conditions

Interventions

TypeNameDescription
DRUGSelinexol and DexamethasoneSelinesol 20mg/tablet 60mg po qw first week, second week, biw third week, namely d1, d8, d15, d18. Dexamethasone 0.75mg/tablet 1.5mg po bid d1-21;

Timeline

Start date
2022-05-01
Primary completion
2025-04-01
Completion
2025-04-01
First posted
2022-04-26
Last updated
2022-04-26

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05347381. Inclusion in this directory is not an endorsement.

Selinexol Combined With Dexamethasone in the Treatment of CAEBV (NCT05347381) · Clinical Trials Directory